Dr. Steven Clark, Devenish Nutrition, has done a great job documenting the health and production issues of the turkey industry in his annual industry survey. When reviewing this list over time, other than when Enrofloxacin was available, one of the top concerns has been “lack of approved, efficacious drugs” (#1 concern reported by the industry in 2015-2016). As the industry continues to move toward more ABF production, that statement will most likely change to “lack of approved, efficacious treatments”. Even if your operation has not been blessed with the distinction of being ABF, times have changed and the industry has lost a lot of tools at its disposal for treating disease.  Read more

Leave a Reply